+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

ePrescribing Market by Offrings, Delivery Mode, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4807798
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The ePrescribing Market grew from USD 147.53 million in 2023 to USD 159.21 million in 2024. It is expected to continue growing at a CAGR of 8.05%, reaching USD 253.79 million by 2030.

ePrescribing, a digital innovation in healthcare, facilitates the electronic transmission of prescription information from healthcare providers to pharmacies. This technology streamlines medication management, reduces errors, and ensures compliance with regulatory requirements. The increasing adoption of Healthcare IT solutions marks a necessity for efficient healthcare delivery, patient safety, and cost reduction. Applications of ePrescribing extend across hospitals, ambulatory care centers, and clinics, with notable end-use in reducing prescription forgery and drug abuse, ensuring timely medication administration, and enhancing the overall quality of care. Key growth influencers include technological advancements, supportive government initiatives like national ePrescribing laws, and the urgent need for error minimization in prescriptions. The integration of big data analytics and AI in this space offers substantial opportunities for market players to extend innovative services, such as predictive analytics for medication adherence and personalized patient care approaches. However, the market faces challenges, including high implementation costs, data security concerns, and interoperability issues between different health IT systems, which can hinder seamless integration. Innovations in cloud-based solutions, blockchain for data security, and advancements in mobile health applications present potential avenues for business growth within the ePrescribing ecosystem. Focusing on developing interoperable solutions and enhancing user education regarding data management and security could mitigate prevalent issues, enhance market penetration, and optimize workflow efficiencies. While the healthcare market continues to evolve towards digital solutions, the ePrescribing sector remains dynamic, impacted by technology shifts and regulatory changes. Companies keen on strengthening their market position should concentrate on collaborative efforts with technology providers and policymakers to navigate complexities, ensure compliance, and develop scalable, secure platforms that address current limitations and future healthcare needs.

Understanding Market Dynamics in the ePrescribing Market

The ePrescribing Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Government initiatives and regulations promoting the use of e-prescribing systems
    • Increasing adoption of electronic health records (EHRs)
    • Emerging demand for improved healthcare quality and patient safety
  • Market Restraints
    • High initial setup and maintenance costs
  • Market Opportunities
    • Rising investments to ​​expand in emerging regions, and advancements in decision support systems
    • Integration with telemedicine, leveraging analytics for personalized medicine
  • Market Challenges
    • Concerns about data privacy and security

Exploring Porter’s Five Forces for the ePrescribing Market

Porter’s Five Forces framework further strengthens the insights of the ePrescribing Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the ePrescribing Market

External macro-environmental factors deeply influence the performance of the ePrescribing Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the ePrescribing Market

The ePrescribing Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the ePrescribing Market

The ePrescribing Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the ePrescribing Market

The ePrescribing Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the ePrescribing Market, highlighting leading vendors and their innovative profiles. These include 75health, Allscripts Healthcare Solutions Inc., athenahealth, Inc., Dosespot by PRN Software, LLC, DrChrono, DrFirst Inc., eazyScripts Technology, LLC, eClinicalWorks, eMDs, Inc. by CompuGroup Medical, Epocrates Inc., Healthie Inc., iCoreConnect, Intelligent Medical Software, Kareo, Inc. by Tebra Technologies, Inc., MDToolbox, MedicalMine Inc., Networking Technology, Inc., NextGen Healthcare, Inc., Optum, Inc., Oracle Corporation, Pabau, Provet Cloud, Qualifacts Systems, LLC, Surescripts, LLC, and Wolters Kluwer N.V..

Market Segmentation & Coverage

This research report categorizes the ePrescribing Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Offrings
    • Services
      • Implementation
      • Network
    • Solution
      • Integrated,
      • Standalone
  • Delivery Mode
    • On premise
    • Web & Cloud based
  • End User
    • Hospitals
    • Pharmacies
    • Physician Offices
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Government initiatives and regulations promoting the use of e-prescribing systems
5.1.1.2. Increasing adoption of electronic health records (EHRs)
5.1.1.3. Emerging demand for improved healthcare quality and patient safety
5.1.2. Restraints
5.1.2.1. High initial setup and maintenance costs
5.1.3. Opportunities
5.1.3.1. Rising investments to ??expand in emerging regions, and advancements in decision support systems
5.1.3.2. Integration with telemedicine, leveraging analytics for personalized medicine
5.1.4. Challenges
5.1.4.1. Concerns about data privacy and security
5.2. Market Segmentation Analysis
5.2.1. Component: Suitability of integrated solutions for broader healthcare IT system
5.2.2. Deployment: Inclination towards on-cloud deployment owing to real time data sharing and updates
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. ePrescribing Market, by Offrings
6.1. Introduction
6.2. Services
6.2.1. Implementation
6.2.2. Network
6.3. Solution
6.3.1. Integrated,
6.3.2. Standalone
7. ePrescribing Market, by Delivery Mode
7.1. Introduction
7.2. On premise
7.3. Web & Cloud based
8. ePrescribing Market, by End User
8.1. Introduction
8.2. Hospitals
8.3. Pharmacies
8.4. Physician Offices
9. Americas ePrescribing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific ePrescribing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa ePrescribing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Rhyl to Launch New Electronic Prescription System for Patients
12.3.2. DrFirst Healthcare Innovations Collaborates with MEDITECH to Power E-Prescribing in Canada
12.3.3. BoomerangFX Partners with DrFirst to Launch E-Prescribing for Aesthetic Medicine Practices Across North America
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. EPRESCRIBING MARKET RESEARCH PROCESS
FIGURE 2. EPRESCRIBING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL EPRESCRIBING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL EPRESCRIBING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2023 VS 2030 (%)
FIGURE 7. GLOBAL EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL EPRESCRIBING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL EPRESCRIBING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES EPRESCRIBING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES EPRESCRIBING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EPRESCRIBING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. EPRESCRIBING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. EPRESCRIBING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL EPRESCRIBING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL EPRESCRIBING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL EPRESCRIBING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. EPRESCRIBING MARKET DYNAMICS
TABLE 7. GLOBAL EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL EPRESCRIBING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL EPRESCRIBING MARKET SIZE, BY IMPLEMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL EPRESCRIBING MARKET SIZE, BY NETWORK, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL EPRESCRIBING MARKET SIZE, BY SOLUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL EPRESCRIBING MARKET SIZE, BY INTEGRATED,, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL EPRESCRIBING MARKET SIZE, BY STANDALONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL EPRESCRIBING MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL EPRESCRIBING MARKET SIZE, BY WEB & CLOUD BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL EPRESCRIBING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL EPRESCRIBING MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL EPRESCRIBING MARKET SIZE, BY PHYSICIAN OFFICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS EPRESCRIBING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. CANADA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 40. CANADA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 41. CANADA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 42. CANADA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 43. CANADA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. MEXICO EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 45. MEXICO EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 46. MEXICO EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 47. MEXICO EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 48. MEXICO EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES EPRESCRIBING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. CHINA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 67. CHINA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 68. CHINA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 69. CHINA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 70. CHINA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. INDIA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 72. INDIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 73. INDIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 74. INDIA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 75. INDIA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. INDONESIA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. JAPAN EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 82. JAPAN EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 83. JAPAN EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 84. JAPAN EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 85. JAPAN EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. MALAYSIA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. PHILIPPINES EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 92. PHILIPPINES EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. SINGAPORE EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 97. SINGAPORE EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 102. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. TAIWAN EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 107. TAIWAN EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. THAILAND EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 112. THAILAND EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 113. THAILAND EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 114. THAILAND EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 115. THAILAND EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. VIETNAM EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 127. DENMARK EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 128. DENMARK EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 129. DENMARK EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 130. DENMARK EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 131. DENMARK EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. EGYPT EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 133. EGYPT EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 134. EGYPT EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 135. EGYPT EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 136. EGYPT EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. FINLAND EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 138. FINLAND EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 139. FINLAND EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 140. FINLAND EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 141. FINLAND EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. FRANCE EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 143. FRANCE EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 144. FRANCE EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 145. FRANCE EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 146. FRANCE EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. GERMANY EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 148. GERMANY EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 149. GERMANY EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 150. GERMANY EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 151. GERMANY EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. ITALY EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 158. ITALY EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 159. ITALY EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 160. ITALY EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 161. ITALY EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. NIGERIA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 168. NIGERIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. NORWAY EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 173. NORWAY EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 174. NORWAY EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 175. NORWAY EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 176. NORWAY EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. POLAND EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 178. POLAND EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 179. POLAND EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 180. POLAND EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 181. POLAND EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. QATAR EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 183. QATAR EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 184. QATAR EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 185. QATAR EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 186. QATAR EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. SPAIN EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 203. SPAIN EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 204. SPAIN EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 205. SPAIN EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 206. SPAIN EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. SWITZERLAND EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 213. SWITZERLAND EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. TURKEY EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 218. TURKEY EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 219. TURKEY EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 220. TURKEY EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 221. TURKEY EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. EPRESCRIBING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 233. EPRESCRIBING MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the ePrescribing Market, which are profiled in this report, include:
  • 75health
  • Allscripts Healthcare Solutions Inc.
  • athenahealth, Inc.
  • Dosespot by PRN Software, LLC
  • DrChrono
  • DrFirst Inc.
  • eazyScripts Technology, LLC
  • eClinicalWorks
  • eMDs, Inc. by CompuGroup Medical
  • Epocrates Inc.
  • Healthie Inc.
  • iCoreConnect
  • Intelligent Medical Software
  • Kareo, Inc. by Tebra Technologies, Inc.
  • MDToolbox
  • MedicalMine Inc.
  • Networking Technology, Inc.
  • NextGen Healthcare, Inc.
  • Optum, Inc.
  • Oracle Corporation
  • Pabau
  • Provet Cloud
  • Qualifacts Systems, LLC
  • Surescripts, LLC
  • Wolters Kluwer N.V.

Methodology

Loading
LOADING...

Table Information